
Dilrasbonu Vohidova, a doctoral student in the Department of Bioengineering
Photo Credit: Courtesy of Rice University
Scientific Frontline: Extended "At a Glance" Summary: Interleukin-10 Biochemical Halo Cloaking
The Core Concept: A bioengineered, localized system that continuously produces the cytokine protein interleukin-10 (IL-10) to create a protective immunological shield around implanted insulin-producing cells.
Key Distinction/Mechanism: Rather than relying on systemic immunosuppressant drugs that leave the entire body vulnerable, this method co-packages IL-10-producing cells alongside pancreatic beta cells within hydrogel capsules. This creates a targeted immune suppression zone that prevents fibrotic scarring and host graft rejection.
Major Frameworks/Components:
- Interleukin-10 (IL-10): A specific cytokine protein identified as highly effective at interacting with immune cells and suppressing localized inflammatory responses.
- Hydrogel Encapsulation: Semipermeable protective capsules utilized to safely house both the therapeutic insulin-producing cells and the IL-10-producing auxiliary cells.
- Fibrosis Mitigation: The active prevention of scarlike tissue accumulation, which normally suffocates implanted foreign materials over time and causes therapeutic failure.


.jpg)




.jpg)




.jpg)
.jpg)

.jpg)

